Bioactivity and the First Transmission Electron Microscopy Immunogold Studies of Short De Novo-Designed Antimicrobial Peptides

被引:41
作者
Azad, Marisa Ann [2 ]
Huttunen-Hennelly, Heidi Esther Katrina [1 ]
Friedman, Cynthia Ross [2 ]
机构
[1] Thompson Rivers Univ, Dept Phys Sci Chem, Fac Sci, Kamloops, BC V2C 5N3, Canada
[2] Thompson Rivers Univ, Dept Biol Sci, Fac Sci, Kamloops, BC V2C 5N3, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
MAGAININ; 2; MECHANISM; INHIBITOR; MEMBRANES; TEMPLATE; PROTEASE;
D O I
10.1128/AAC.01148-10
中图分类号
Q93 [微生物学];
学科分类号
071005 [微生物学];
摘要
In light of the era of microbial drug resistance, the current study aimed to better understand the relationships between sequence, higher-order structure, and mechanism of action for five designed peptides against multidrug-resistant (MDR) pathogens. All peptides studied were 15 residues long, were polycationic, adopted alpha-helical structures within hydrophobic environments (excluding the D-amino acid-substituted peptide MA-d), and contained N-terminal glycine residues, a novel antimicrobial peptide (AMP) design principle. Increasing hydrophobicity enhanced MICs (<= 500 mu g/ml to < 7.4 mu g/ml) without significantly increasing hemolytic activity (18% maximum hemolysis at 3,400 mu g/ml). To the best of our knowledge, this is the first study to have successfully adapted and used a transmission electron microscopy (TEM) immunogold method to investigate the mechanism of action of short (similar to 15 residues long) AMPs within bacteria. We propose a "floodgate" mechanism to possibly explain membrane deformation and the relative absence of membrane-associated peptides 10 h into incubation.
引用
收藏
页码:2137 / 2145
页数:9
相关论文
共 43 条
[1]
[Anonymous], 1986, NMR of proteins and nucleic acids
[2]
Candida albicans VPS1 contributes to protease secretion, filamentation, and biofilm formation [J].
Bernardo, Stella M. ;
Khalique, Zachary ;
Kot, John ;
Jones, Jason K. ;
Lee, Samuel A. .
FUNGAL GENETICS AND BIOLOGY, 2008, 45 (06) :861-877
[3]
STRUCTURE-FUNCTION STUDIES OF AMPHIPHILIC ANTIBACTERIAL PEPTIDES [J].
BESSALLE, R ;
GOREA, A ;
SHALIT, I ;
METZGER, JW ;
DASS, C ;
DESIDERIO, DM ;
FRIDKIN, M .
JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (09) :1203-1209
[4]
Black J.G., 1996, MICROBIOLOGY PRINCIP
[5]
Antibacterial peptides: basic facts and emerging concepts [J].
Boman, HG .
JOURNAL OF INTERNAL MEDICINE, 2003, 254 (03) :197-215
[6]
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[7]
Antimicrobial peptides: Pore formers or metabolic inhibitors in bacteria? [J].
Brogden, KA .
NATURE REVIEWS MICROBIOLOGY, 2005, 3 (03) :238-250
[8]
Cavanagh J., 1996, Protein Nmr Spectroscopy: Principles and Practice
[9]
Rational design of α-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index [J].
Chen, YX ;
Mant, CT ;
Farmer, SW ;
Hancock, REW ;
Vasil, ML ;
Hodges, RS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (13) :12316-12329
[10]
Amphiphilic α-helical antimicrobial peptides and their structure/function relationships [J].
Dennison, SR ;
Wallace, J ;
Harris, F ;
Phoenix, DA .
PROTEIN AND PEPTIDE LETTERS, 2005, 12 (01) :31-39